Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 1 - 10 of 11

Subscribe

Press

Recipharm subsidiary files infectious disease drug application in European markets

2013.12.16 Read more

Press

Recipharm in new German market collaboration for development services

2013.10.15 Read more

Press

Recipharm to expand lyophilization capacity with €32 million investment in Germany

2013.10.08 Read more

Press

Abstral®, manufactured and packaged by Recipharm AB for Kyowa Hakko Kirin, has been approved in Japan

2013.09.23 Read more

Press

Recipharm AB provides access to Asmasal Clickhaler dossier for Vectura plc Chinese market approval

2013.06.11 Read more

Press

Recipharm Annual report 2012

2013.05.14 Read more

Press

Recipharm and Synthonics join forces to promote novel drug delivery technology

2013.05.07 Read more

Press

Recipharm site in France approved for supply of manufactured products to Japan

2013.03.26 Read more

Press

Recipharm supplies clinical trial material for FDA approved phase IIb study sponsored by PledPharma

2013.02.12 Read more

Press

Recipharm Appoints Prof. Hans Lennernäs to one of its operating Boards

2013.02.05 Read more

Pagination

  • Current page 1
  • Page 2
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2019 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå